An accelerated pathway for targeted cancer therapies

Mark McClellan, Joshua Benner, Richard Schilsky, David Epstein, Ray Woosley, Stephen Friend, David Sidransky, Cindy Geoghegan, David Kessler

Research output: Contribution to journalReview articlepeer-review

Abstract

A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.

Original languageEnglish (US)
Pages (from-to)79-80
Number of pages2
JournalNature Reviews Drug Discovery
Volume10
Issue number2
DOIs
StatePublished - Feb 1 2011

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'An accelerated pathway for targeted cancer therapies'. Together they form a unique fingerprint.

Cite this